Zeke Capital Advisors’s Celgene Corp CELG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q4
Sell
-17,778
Closed -$1.76M 589
2019
Q3
$1.76M Sell
17,778
-2,546
-13% -$242K 0.16% 110
2019
Q2
$1.88M Sell
20,324
-1,265
-6% -$120K 0.18% 101
2019
Q1
$2.04M Sell
21,589
-8,050
-27% -$704K 0.19% 97
2018
Q4
$1.9M Buy
29,639
+19,952
+206% +$1.47M 0.18% 95
2018
Q3
$867K Buy
+9,687
New +$856K 0.07% 272
2018
Q2
Sell
-9,326
Closed -$832K 723
2018
Q1
$832K Buy
9,326
+1,456
+19% +$140K 0.08% 230
2017
Q4
$821K Sell
7,870
-5,265
-40% -$594K 0.09% 191
2017
Q3
$1.92M Buy
13,135
+7,410
+129% +$1.01M 0.26% 68
2017
Q2
$744K Buy
5,725
+350
+7% +$42.9K 0.14% 94
2017
Q1
$669K Buy
5,375
+1,823
+51% +$218K 0.14% 84
2016
Q4
$411K Buy
+3,552
New +$396K 0.11% 98

Other funds holding CELG

Zeke Capital Advisors's CELG Position: Q4 2019 in Review

Zeke Capital Advisors sold out of Celgene Corp (CELG) in Q4 2019, closing a stake of 17,778 shares — an estimated $1.76M sold.

Zeke Capital Advisors first reported a position in CELG in Q4 2016 and held it in 11 quarters. The position peaked at $2.04M in Q1 2019. 4 funds tracked by Wall St. Rank hold CELG as of Q4 2019.

  • Zeke Capital Advisors reported no remaining Celgene Corp position as of Q4 2019 after selling out during the quarter.
  • Zeke Capital Advisors sold 17,778 Celgene Corp shares in Q4 2019, an estimated $1.76M.
  • Zeke Capital Advisors first reported a position in Celgene Corp in Q4 2016 and held it in 11 quarters.
  • Zeke Capital Advisors's Celgene Corp position peaked at $2.04M in Q1 2019.
  • 4 funds tracked by Wall St. Rank held Celgene Corp as of Q4 2019.

Based on Zeke Capital Advisors's 13F filing for Q4 2019, filed 17 Jan 2020.